Cellular Senescence and Skin Aging

Cellular senescence is a biological state in which a cell enters a stable arrest of the cell cycle, meaning it’s no longer progressing normally toward division, but still remains metabolically active.

Senescence can arise in response to many forms of cellular stress, including DNA damage, oxidative stress, damage or shortening of chromosome-protecting telomeres, and abnormal growth signals that the cell interprets as potentially dangerous.

In skin, chronic ultraviolet exposure is particularly relevant. Recent human skin mapping using single-cell RNA sequencing and spatial transcriptomics found increased signatures of cellular senescence with both chronological aging and photoaging, with photoaged skin showing a particularly strong senescent-cell burden.

But a critical distinction is often lost when senescence enters the popular anti-aging conversation:

Transient senescence can participate in processes that have positive outcomes, including tissue remodeling, tumor suppression, and wound repair. The emerging concern in aging is not simply that senescence occurs, but that senescent cells may persist and accumulate, changing the environment around them over time. Reviews of skin aging and wound biology increasingly emphasize this difference between temporary, context-dependent senescence and chronic senescent-cell accumulation.

The objective of aging science should not automatically be to prevent senescence from ever occurring. Biology is rarely that simple.

This is where senescence becomes especially interesting. Many senescent cells develop changes in what they secrete into their surrounding environment.

Researchers collectively describe many of these secreted factors as the:

Depending on the cell type, the trigger that produced senescence, and the biological context, the SASP may contain combinations of:

There is no single universal SASP.

Senescent cells are heterogeneous, and their secretory behavior can differ substantially depending on tissue, cell type, timing, and stimulus. Likewise, scientists do not currently have one universal biomarker that can identify every senescent cell in every context. Researchers instead use combinations of markers and cellular characteristics.

But the broader implication is powerful:

And when senescent cells persist, some of that signaling can become increasingly inflammatory, matrix-altering, or disruptive to normal tissue homeostasis.

That shifts the aging conversation from one cell to an entire cellular environment.

To understand why this matters for visible skin aging, we have to talk about fibroblasts.

Fibroblasts live throughout the dermis and play a central role in maintaining the extracellular matrix, or ECM.

They are involved in the production and organization of structural proteins and in the continuous maintenance of the dermal environment.

Fibroblasts also respond to mechanical forces within the extracellular matrix, interact with neighboring cells, and participate in tissue signaling and repair.

Recent human skin research examining senescence at single-cell resolution associated senescent reticular dermal fibroblasts with reduced expression of collagen- and elastic-fiber-related programs. Other work has connected fibroblast senescence with altered inflammatory signaling, matrix degradation, and changes in communication across skin compartments.

That raises a much bigger question than simply:

We also need to understand the biological environment in which that fibroblast is operating.

One of the most important shifts occurring in aging biology is the growing recognition that cells cannot be understood independently from the tissue surrounding them.

Consider collagen:

The extracellular matrix gives fibroblasts more than structural support. It also provides mechanical information.

Fibroblasts attach to collagen fibrils and experience physical tension through those interactions. As collagen becomes increasingly fragmented with age, those mechanical relationships change.

Research in human dermal fibroblasts has shown that loss of normal fibroblast spreading and mechanical force can increase signaling through AP-1, which is our activator protein. It’s the precursor that activates MMP (matrix metalloproteinase) activity to target and break down collagen. At the same time, altered ECM mechanics can impair signaling involved in new matrix production. So, in other words, we can break down more collagen than we rebuild.

This creates the possibility of a feed-forward loop:

Neither can be completely understood without the other.

This is one reason we believe the traditional anti-aging model of simply "stimulating collagen" is too narrow and, more importantly, incomplete.

Cellular senescence becomes even more interesting when we consider that its effects may extend beyond the senescent cell itself.

Experimental studies have shown that factors released from senescent fibroblasts can change extracellular-matrix-related gene expression in nearby fibroblasts, including increased expression of matrix-degrading enzymes and changes in collagen and elastin-associated pathways.

This means that the same senescent cells that were activated during repair may not have departed the way they should have. Now, they are converting to potentially reductive or even dangerous behaviors.

This phenomenon is one reason researchers increasingly study senescence as a tissue-level process rather than simply a cell-autonomous event.

In other words:

That does not mean every senescent cell is destructive, nor that every age-related change in fibroblast function is caused by senescence.

In fact, research has also identified age-associated fibroblast dysfunction that appears to occur independently of classical cellular senescence. Reduced collagen production, for example, cannot simply be attributed to senescent cells alone.

Taken together, the emerging science suggests a broader way of thinking about visible skin aging.

A simplified model might look like this:

This should not be interpreted as one universal sequence responsible for every aspect of skin aging.

It’s better understood as an interconnected biological network in which cellular stress, senescence, extracellular-matrix deterioration, inflammation, mechanical signaling, and altered cellular communication can influence one another.

That distinction changes the question. Instead of asking only:

We are starting to ask:

The growing understanding of cellular senescence has created an entirely new area of aging research known broadly as senotherapeutics.

Two major strategies currently dominate this field.

These are fundamentally different approaches.

And neither should be confused with conventional cosmetic anti-aging claims.

A 2026 review focused specifically on dermatology describes both senolytic and senomorphic approaches as active areas of geroscience research, while emphasizing the complexity of senescent-cell biology and the protective roles of transient senescence.

This field is incredibly promising, but it’s also still very young.

Questions remain around identifying the right cells, distinguishing beneficial from harmful senescence, developing reliable biomarkers, understanding timing, and avoiding disruption of the physiological functions that senescence can serve.

Traditional skincare development often begins with an output:

Those outputs still matter.

But increasingly, longevity and geroscience research are encouraging a more upstream view of biology.

Instead of asking only how strongly one pathway can be stimulated, we can ask how the surrounding biological system influences that pathway.

For skin, that means studying areas such as:

At Alchemy 21/12, we believe the future of advanced skincare will increasingly move away from treating skin aging as a collection of isolated deficiencies.

Skin is a living tissue. Its cells communicate. Its extracellular matrix sends mechanical signals back to the cells embedded within it.

Inflammatory signaling can influence structural biology. Structural deterioration can change cellular behavior.

Cellular behavior can further change the extracellular environment.

That does not make established targets like collagen, elastin, pigmentation, hydration or barrier function irrelevant.

It puts them in context.

We believe the more interesting question is not simply:

But rather:

Cellular senescence is one emerging piece of that question, and though it’s not the whole answer, it may help explain why skin aging cannot be understood solely by measuring what the skin has lost.

Cellular senescence research is moving quickly, and several areas are particularly important to watch.

For years, anti-aging skincare has focused primarily on the substances that aging skin loses.

The emerging science of cellular senescence asks us to look at something different:

A fibroblast does not exist simply to produce collagen.

A senescent cell is not simply an old cell waiting to be removed.

The extracellular matrix is not merely structural scaffolding.

And visible skin aging is not the result of one broken pathway.

The deeper we look, the more skin begins to resemble what it has always been:

Understanding that network may ultimately change how we think about skin aging altogether.